| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 71 |
| 1 | ADALIMUMAB | 38 |
| 2 | METHOTREXATE SODIUM | 18 |
| 3 | METHOTREXATE | 17 |
| 4 | ETANERCEPT | 16 |
| 5 | RISEDRONATE SODIUM | 16 |
| 6 | ERGOCALCIFEROL | 15 |
| 7 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 14 |
| 8 | GABAPENTIN | 14 |
| 9 | CALCIUM | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAMPHOR (SYNTHETIC), EUCALYPTUS OIL, AND MENTHOL | 1 | 0.0063 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 14 | 0.0051 |
| 2 | HYDROCHLORIC ACID | 1 | 0.0045 |
| 3 | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE | 1 | 0.0027 |
| 4 | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE | 1 | 0.0027 |
| 5 | RIFAPENTINE | 1 | 0.0019 |
| 6 | TAZAROTENE | 1 | 0.0008 |
| 7 | HALOBETASOL PROPIONATE | 1 | 0.0007 |
| 8 | ALENDRONATE SODIUM | 71 | 0.0007 |
| 9 | CALCITONIN SALMON | 2 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vitamin D [EPC] | 22 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 20 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 17 |
| 4 | Vitamin C [EPC] | 16 |
| 5 | Provitamin D2 Compound [EPC] | 15 |
| 6 | Estrogen [EPC] | 14 |
| 7 | Calcium [EPC] | 13 |
| 8 | Corticosteroid [EPC] | 13 |
| 9 | Opioid Agonist [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Calcitonin [EPC] | 2 | 0.0006 |
| 2 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 3 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0002 |
| 5 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 6 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 7 | Parathyroid Hormone Analog [EPC] | 12 | 0.0001 |
| 8 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 9 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |